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Effort testing in dementia assessment: A systematic review 
 
Claire McGuire, Stephanie Crawford and Jonathan J Evans 
 
 
 
Abstract 
Objective 
Interpretation of neuropsychological test data is only valid when appropriate effort has been 
exerted. Research however suggests that neuropsychologists do not always formally test for 
effort and that this may especially be the case in the context of dementia assessment. This 
review systematically examined the literature that has investigated the use of both purpose-
built and embedded effort-sensitive indices in dementia, mild cognitive impairment (MCI) 
and healthy control samples. The aim was to determine which tests of effort are most 
sensitive to suboptimal effort and least sensitive to the type of cognitive impairment seen in 
dementia. 
Methods 
A systematic search of databases was conducted to October 2017. There was no start date. 
Results 
Twenty five studies were included for review. The studies were divided into two categories 
according to methodology. One category of studies (n=5) was reviewed using a tailored 
methodological quality rating checklist whilst the remaining studies (n=20) were reviewed 
using the Crowe Critical Appraisal Tool (CCAT).  
Conclusions 
The results of this review suggest that PVTs which take a hierarchical approach to effort 
testing such as the WMT, MSVT and NV-MSVT are preferable for use with older adults who 
are under investigation for possible dementia. These tests go above and beyond the traditional 
pass/fail approach of more traditional tests of effort since they allow the examiner to analyse 
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the examinee’s profile of scores. The methodological limitations and challenges involved in 
this field of research are discussed. 
 
Introduction 
Cognitive testing is used in many clinical settings, alongside information gathered 
from other sources, to develop a comprehensive understanding of a person’s difficulties. 
Scores on cognitive tests are usually interpreted alongside published normative data which 
assume that the examinee has put forth good effort. The value and accuracy of an assessment 
therefore relies on the quality of the data to be interpreted and, as such, it is of great 
importance that the clinician has evaluated the examinee’s level of effort and motivation 
during the assessment process. Effort testing is considered a crucial component of 
neuropsychological evaluation according to both the British Psychological Society (BPS; 
McMillan et al., 2009) and the American Academy of Clinical Neuropsychology (AACN; 
Heilbronner et al., 2009).  
This has led to the creation of both purpose-built tests designed to detect non-credible 
effort such as the Test of Memory Malingering (TOMM; Tombaugh, 1996), the Word 
Memory Test (WMT; Green, 2003) and the Rey 15-Item Test (RFIT; Rey, 1964) and those 
which have been developed from existing neuropsychological test batteries such as the Effort 
Index (EI; Silverberg, Wertheimer, & Fichtenberg, 2007) and the Effort Scale (ES; Novitski, 
Steele, Karantzoulis & Randolph, 2012) both derived from the Repeatable Battery for the 
Assessment of Neuropsychological Status (RBANS; Randolph, Tierney, Mohr & Chase, 
1998). Effort tests are also known as symptom validity tests (SVTs) or performance validity 
tests (PVTs) however Larrabee (2012) distinguishes between these two terms. SVTs are self-
report measures which tell the examiner whether a person’s symptomatic complaint is 
reflective of their true experience of symptoms whereas PVTs are cognitive tests which allow 
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the examiner to know whether the examinee’s test performance is reflective of true cognitive 
ability. For the purposes of this review, the term performance validity test (PVT) will be used 
alongside test of effort. 
There also exist published criteria which can aid clinicians in making a judgement 
about an examinee’s level of effort or motivation. One such set of criteria was published by 
Slick, Sherman and Iverson (1999) in a landmark paper which encouraged clinicians to apply 
a ‘discrepancy method’ to their judgement of poor effort (e.g. attending to inconsistencies 
between test scores and observed behaviours from the same domain). Slick et al (1999) 
propose inspecting an examinee’s pattern of performance (e.g. comparing scores on easy and 
difficult items to identify inconsistent patterns of scores) alongside evidence from other 
sources such as the presence or absence of a substantial, external incentive and significant 
inconsistencies or discrepancies in the individual’s self-report. 
Despite these recommendations, however, it appears that effort tests are not always 
routinely administered as part of cognitive assessment. One study which surveyed 130 UK 
neuropsychologists about their practices and beliefs regarding tests of effort, found that 
whilst 59% of respondents working in forensic settings said that they always used a test of 
effort, only 15% of respondents working in other clinical settings said the same. One third of 
the respondents in this study said that there was no need to use a dedicated test of effort 
because non-credible symptoms were evident from the results of other tests and from the 
client’s general presentation during assessment (McCarter, Walton, Brooks & Powell, 2009). 
Research has found, however, that clinicians’ subjective evaluation of test validity is often 
highly inaccurate (Faust, 1995; Faust, Hart & Guilmette, 1988; Heaton, Smith, Lehman & 
Vogt, 1978) and that analysing performance on traditional neuropsychological measures 
alone is an unreliable method of detecting invalid or malingered performance (Van Gorp et 
al., 1999). It should be noted however that there is a cultural divide regarding the use of effort 
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testing as research has shown that a majority of clinicians in the United States routinely test 
for effort as part of neuropsychological assessment (Schroeder, Martin & Odland, 2016). 
It may be that some clinicians consider effort tests to only be of relevance when there 
is suspicion that an individual is deliberately feigning symptoms and indeed the majority of 
the literature on effort testing focuses on populations in which the deliberate feigning of 
symptoms is thought to be most prevalent, e.g. medico-legal settings and disability payment 
assessments. Nevertheless, literature does exist which examines the validity and reliability of 
effort testing in various clinical groups such as brain injury (Green, Rohling, Lees-Haley & 
Allen, 2001; Hampson, Kemp, Coughlan, Moulin & Bhakta, 2014), depression (Ashendorf, 
Constantinou & McCaffrey, 2004), chronic fatigue syndrome (van der Werf, Prins, Jongen, 
van der Meer & Bleijenberg, 2000) and conversion and somatoform disorders (Boone & Lu, 
1999). 
There is, however, a lack of information on how people with varying degrees of mild 
cognitive impairment (MCI) or dementia would be expected to perform on tests of effort as 
individuals with dementia are often excluded from samples used for effort test validation 
(Dean, Victor, Boone, Philpott & Hess, 2009).  
It may be that tests of effort are not routinely validated in samples of older adults who 
are under investigation for memory problems because it is thought that they are unlikely to be 
feigning symptoms. Indeed, a study found that as few as 2% of litigants and those seeking 
other forms of compensation alleged dementia (Mittenberg, Patton, Canyock & Condit, 
2002). It is important however to approach the issue of effort from a wider definition than 
that of deliberate malingering. There are many reasons unrelated to financial gain that can 
result in non-credible effort such as: depression, medication side effects, stress, lack of 
interest, fatigue, lack of comprehension of the utility of the tests or motivation to be in a ‘sick 
role’ (Barker, Horner & Bachman, 2010). When conducting cognitive assessment with older 
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people it is also important to consider medical and physical issues which could impact on an 
examinee’s performance on a test of effort such as visual impairment/disturbance, language 
difficulties and chronic health conditions which can cause fatigue.  
In order for clinicians to be able to adequately assess the reliability of data resulting 
from cognitive assessment in older adults presenting with memory problems, they must know 
which effort tests are the most suitable for use with this population. 
To date there is no systematic review which examines the literature on the use of 
effort testing in dementia assessment. 
 
Systematic review objectives 
This review evaluates the literature on effort testing in dementia assessment with the 
following objectives: review which effort tests provide the lowest rate of false-positive error 
in people with MCI and dementia and to examine the relationship between dementia severity 
and false-positive rates. 
 
Methods 
Search Strategy 
The following electronic bibliographic databases were searched: PsycINFO, Cinahl, 
EMBASE, Medline and Psychology and Behavioural Sciences Collection. The search did not 
have a start date limit. The end date was October 2017. The following search criteria were 
used in all databases: ([malingering OR “test* of effort” OR “symptom validity test*” OR 
“symptom validity” OR “effort test*” OR “validity test*” OR “performance validity” OR 
“non-credible effort” OR “suspect effort”] AND [dementia OR MCI OR “mild cognitive 
impairment” OR “geriatric*”]). Titles and abstracts of studies identified were examined to 
identify those pertaining to effort testing in dementia assessment. Reference lists of all 
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included papers were also examined to identify any further relevant studies. All the titles and 
abstracts of identified papers featuring the use of effort testing in dementia assessment were 
screened against the following criteria: 
Inclusion criteria: Studies investigating the performance of dementia and/or MCI samples 
on tests of effort. 
 
Exclusion Criteria: Studies which solely used a sample of participants asked to simulate 
MCI or dementia. Single case studies. 
 
Methodological quality 
In order to rate the methodological quality of the studies included in this review, the 
studies were separated into two different categories based on their methodology. The first 
category pertained to papers in which a reference standard is used to establish if a diagnosis is 
present or absent in the participants (in this case the diagnosis would be credible or non-
credible effort) and then results on the index test (the effort test(s) of interest) are compared 
between the two groups. A reference standard is the best available method for establishing 
the presence or absence of a particular diagnosis. To rate the papers included in this first 
category (n=5), a checklist was developed based on the SIGN Methodology Checklist 5 for 
Studies of Diagnostic Accuracy (SIGN, 2007) and the Standards for the Reporting of 
Diagnostic accuracy studies statement (STARD; Bossuyt et al., 2015). The quality rating 
checklist had a maximum score of 28 points.  
The second category covers the majority of the papers included in this review (n=20) in 
which the researchers have recruited a sample of participants whom they consider not to meet 
the diagnosis (of non-credible effort). In these studies the researchers have either excluded 
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participants who may have motivation to feign impairment (involvement in litigation/in 
receipt of disability payments) or they have assumed that their sample will exert credible 
effort by virtue of having a diagnosis of dementia/MCI. To rate the methodological quality of 
these papers, the Crowe Critical Appraisal Tool (CCAT; Crowe & Sheppard, 2011) was used. 
The CCAT contains 54 reporting items in 8 categories and has a maximum score of 40 
points. 
All papers were rated by the author. A second rater assessed 12/25 (48%) of the papers to 
examine the inter-rater reliability of the checklists. Across all the checklist items in the 
quality rating tools, there was 84% agreement between raters. Where discrepancies occurred, 
these were resolved through discussion. 
 
Outcome of search process 
A total of 25 papers met the inclusion criteria and are included in this review. Figure 1 is 
a flow diagram illustrating the systematic process of identifying the 25 papers included.  
 
Results 
In this review, sensitivity (also called the true positive rate) refers to the ability of the 
tests to identify non-credible effort when non-credible effort is present. Specificity (also 
called the true negative rate) refers to the ability of the tests to identify credible effort when 
credible effort is present. The majority of the studies included in this review involved 
participants who were deemed to be exerting credible effort due to not being involved in 
litigation or by virtue of having an established diagnosis of MCI or dementia and therefore 
having little to no reason to feign impairment (n=20). This means that the methodology 
involved administering tests of effort to participants who were already deemed to be exerting 
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credible effort. These studies cannot possibly investigate the sensitivity levels of the effort 
test(s) in question (there are no true positives present in their samples). They report 
specificity levels only. 
The studies (n=5) which include both participants who are and are not exerting 
credible effort are able to report both sensitivity and specificity levels with the exception of 
Schroeder et al. (2012) who used the RBANS Effort Scale as a reference standard but who 
deemed all of their participants to be exerting credible effort therefore they report specificity 
levels only. See Tables 1 to 12 for data extraction tables which include demographic 
information and sensitivity and specificity levels where appropriate. This information is listed 
per PVT. 
The majority of the studies included in this review therefore report specificity levels 
but not sensitivity levels. 
The results of the studies included in this review will be reported by effort test and 
grouped by purpose-built vs embedded effort tests: 
 
Purpose-built PVTs 
1. Test of Memory Malingering (TOMM; Tombaugh, 1996). 
2. Rey 15 Item Test (RFIT; Rey, 1964). 
3. The Coin in the Hand (CIH; Kapur, 1994). 
4. Word Memory Test (WMT; Green, 2003). 
5. Medical Symptom Validity Test (MSVT; Green, 2004). 
6. Non-Verbal Symptom Validity Test (NV-MSVT; Green, 2008). 
7. Amsterdam Short Memory Test (ASTM; Schagen, Schmand, de Sterke &, 
Lindeboom, 1997). 
8. Dot Counting Test (DCT; Rey, 1941). 
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9. Finger Tapping Test (FTT; Reitan & Wolfson, 1993).  
Embedded PVTs 
1. Repeatable Battery for the Assessment of Neurological Status (RBANS; 
Randolph, Tierney, Mohr & Chase, 1998) 
a. Effort Index (EI; Silverberg, Wertheimer & Fichtenberg, 2007). 
b. Effort Scale (ES; Novitski, Steele, Karantzoulis & Randolph, 2012). 
c. Two novel indices (PVI and CRIER) (Paulson, Horner & Bachman, 2015). 
2. Reliable Digit Span (RDS; Greiffenstein, Baker & Gola, 1994). 
 
Please note that the study by Dean, Victor, Boone, Philpott and Hess (2009) included in 
this review investigated a total of 18 stand-alone and embedded effort tests. It was out with 
the scope of this review to include all of these PVTs however those which have also been 
investigated by other studies have been included. These are: TOMM, RFIT, DCT and RDS. 
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Purpose-built PVTs 
1. Test of Memory Malingering (TOMM; Tombaugh, 1996). 
Seven of the 25 papers included in this review investigated the use of the TOMM, one of 
the most widely used PVTs. The results of the studies can be found in Table 1. The TOMM is 
a picture-recognition, forced-choice, purpose-designed effort test consisting of two learning 
trials and an optional retention trial. A cut-off of <45 for Trial 2 suggests that a score lower 
than this is indicative of poor effort.  
Across the seven studies, pass rates for the dementia groups (Trial 2 <45) ranged from a 
low of 24% (Teichner & Wagner, 2004) to a high of 95% (Rudman, Oyebode, Jones & 
Bentham, 2011). Only two of the seven studies investigated the utility of the TOMM in MCI 
samples (Teichner & Wagner, 2004; Walter, Morris, SwierVosnos & Pliskin, 2014). Both 
studies found similar pass rates for these samples (91.7% and 90.3% respectively). 
Drawing comparisons between the results of these studies is compromised to an extent, 
because they use different criteria for diagnosing dementia (DSM-III, DSM-IV and the 
ADRDA-NINDS) and they also assess cognitive function using different tools (five report 
MMSE scores, one uses the RBANS and one the CAMCOG). This is important because one 
reason for the discrepancy in results across studies might be that the samples include 
individuals with significantly different levels of cognitive function. The difference in results 
reported by Tombaugh (1997) and Teichner and Wagner (2004) may be explained by 
dementia severity. Tombaugh states that 4/37 dementia participants (i.e. 10% of their 
dementia sample) who scored below 40 on the TOMM, had MMSE scores of 7, 15, 16 and 
19. The paper does not, however, give any detail about the MMSE scores of the rest of the 
sample (presumably the remaining participants all of whom scored > 45 in this sample had 
MMSE scores of >19). In Teichner and Wagner’s (2004) sample however, 9/21 (i.e. 42.9% of 
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their dementia sample), had MMSE scores lower than 19. It may therefore be that Teichner 
and Wagner’s (2004) sample was more cognitively impaired than that of Tombaugh’s (1997). 
Rudman and colleagues (2011) found a specificity of 95% for the TOMM, however this was 
in a sample of mildly impaired dementia participants. Specificity dropped to 36% in their 
moderate to severely impaired sample. 
Bortnik et al. (2013), Teichner and Wagner (2004) and Tombaugh (1997) all give data for 
alternative cut-offs. A cut-off of 40 produced a specificity of 89.2% in Tombaugh’s sample 
however the same cut-off yielded only 48% specificity in Teichner and Wagner’s dementia 
sample (compared to 97.3% of their MCI group). In the Bortnik et al. (2013) good effort 
dementia sample, the TOMM reached 95% specificity when the cut-off was lowered to 34 
There are also some flaws in the reporting of results across studies. Tombaugh (1997) 
which received a score of 30/40 on the CCAT, states that ‘a cutting score of 45 on Trial 2 
produced a high level of specificity. It correctly classified 95% of all non-demented patients 
(91% of all patients) as non-malingering’ (p.265). As previously mentioned however, 89.1% 
of Tombaugh’s (1997) dementia sample passed the TOMM but only when a cut-off score of 
<40 was used. This drops to 72.9% with the recommended cut-off of <45, meaning that 
approximately one in four of their dementia patients were incorrectly classified as putting 
forth non-credible effort. 
Additionally, with the exception of Bortnik, Horner and Bachmann (2013) sample sizes 
across studies were small. 
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Table 1. Data extraction table for the Test of Memory Malingering (TOMM; Tombaugh, 1996) – all results refer to a cut-off score of <45/40 on 
TOMM Trial 2 unless otherwise stated. 
Study Sample (n) Mean Age 
(SD) 
Mean 
Education 
(SD) 
Impairment 
measure 
Mean Score 
on 
Impairment 
Measure (SD) 
±TOMM 
Sensitivity 
(%) 
*TOMM 
Specificity 
(%) 
Quality 
Rating 
score  
Walter et al. (2014) Dementia (mod/sev) (31) 69.48 (7.86) 15.63 (2.92) RBANS total 
score 
60.7 (7.48) n/a 79 31/40 
(78%) 
MCI (28) 66.02 (8.02) 14.68 (2.09) 80.72 (4.47) n/a 91 
Controls (30) 71.43 (8.99) 16.33 (3.19) 96.73 (8.61) n/a 100 
Bortnik et al. (2013) Good effort (119) 77 (7) 11.42 (4) MMSE 20.8 (5) n/a 45 78 
37 91 
34 95 
20/28 
(71%) 
Suspect effort (9) 72 (8.13) 10.44 (2.3) 17.9 (4.5) 45 100 
37 78 
34 67 
n/a 
Rudman et al. (2011) Dementia (mild) (20) 58.3 Not reported CAMCOG 88.60 (5.03) n/a 95 28/40 
(70%) 
Dementia (mod/sev) (22) 62.45 (16.21) n/a 36 
Dean et al. (2009) Dementia (20) Not reported Not reported MMSE 19.2 (4.4) n/a 45 30/40 
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(75%) 
Merten et al. (2007) AD (20) 73.5 (4.8) 11.7 (3.3) MMSE 22.2 (2.9) n/a 70 30/40 
(75%) 
Controls (14) 76.6 (6.7) 11.3 (3.7) 28.9 (1.0) n/a 100 
Teichner & Wagner (2004) Dementia (21) 75.3 (6.1) 13.6 (3.3) MMSE 
WAIS FSIQ 
19.9 (2.8) 
MMSE 
80.6 (12) 
WAIS 
n/a 45 24 
42 38  
40 48 
27/40 
(68%) 
MCI (36) 70.6 (8.1) 14.2 (3.2) 25.6 (2.5) 
MMSE 
90.8 (14.8) 
WAIS 
n/a 45 91.7 
42 94.4 
40 97.3 
Controls (21) 65.6 (8.6) 14.2 (3.6) 28.3 (1.7) 
MMSE 
99.1 (15.3) 
WAIS 
n/a 45 100 
42 100 
40 100 
Tombaugh (1997) Dementia (37) 69.48 (7.86) 72.1 (7.6) MMSE Not reported n/a 45 72.9 
40 89.2 
30/40 
(75%) 
Controls (13) 66.02 (8.02) 45.9 (15) 45 100 
40 100 
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*Specificity means that the test correctly identified credible effort (i.e. the proportion of true negatives). 
±Sensitivity means that the test correctly identified non-credible effort (i.e. the proportion of true positives).    
RBANS  = Repeatable Battery for the Assessment of Neuropsychological Status                                                                                                                                                                                                                                          
MMSE = Mini-Mental State Examination                                                                                                                                                                                                                                   
CAMCOG = Cambridge Cognitive Examination                                                                                                                                                                                                                                    
WAIS FSIQ = Wechsler Adult Intelligence Scale, Full Scale Intelligence Quotient 
AD = Alzheimer’s Dementia                                        
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2. Rey 15 Item Test (RFIT; Rey, 1964). 
Alongside the TOMM, the RFIT is one of the most widely used effort tests in clinical 
practice (Slick, Tan, Strauss & Hultsch, 2004). The task consists of studying a card for 10 
seconds which has five rows of three characters. The test consists of a free-recall and an 
optional recognition trial. A score lower than 9 on the free-recall trial and a score lower than 
20 on the combination equation are said to be indicative of non-credible effort (Boone, 
Salazar, Lu, Warner-Chacon & Razani, 2002). The results of studies investigating the RFIT 
can be found in Table 2. 
Bortnik, Horner and Bachman (2013) reported a high sensitivity to non-credible effort in 
their ‘suspect effort’ group (100%) but a very low specificity (28%) in their good effort 
group. Rudman, Oyebode, Jones and Bentham (2011) found a similar specificity level (27%) 
for their moderate/severe dementia group. The studies use different tools to assess cognitive 
impairment (MMSE and CAMCOG) however research suggests these screens are highly 
correlated (Heinik, Solomesh & Berkman, 2004) therefore it was possible to note that both 
Rudman and Bortnik’s dementia samples were equally impaired (mean CAMCOG 62.45, 
mean MMSE 20.8). Rudman found far better specificity in their mildly impaired sample 
(85% specificity, mean MMSE 20.8). Both studies performed similarly on the quality rating 
checklists (70%).
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Table 2. Rey 15 Item Test (RFIT; Rey, 1964) – Bortnik, Horner and Bachman (2013) use a cut-off of <9, Rudman, Oyebode, Jones and Bentham 
(2011) use a cut-off of <8. 
Study Sample (n) Mean Age 
(SD) 
Mean 
Education 
(SD) 
Impairment 
measure 
Mean Score 
on 
Impairment 
Measure (SD) 
±RFIT 
Sensitivity 
(%) 
*RFIT 
Specificity 
(%) 
Quality Rating score  
Bortnik et al. (2013)  Good effort 
(119) 
77 (7) 11.42 (4) MMSE 20.8 (5) n/a 28 20/28 (71%) 
Suspect effort 
(9) 
72 (8.13) 10.44 (2.3) 17.9 (4.5) 100 n/a 
Rudman et al. (2011) Dementia 
(mild) (20) 
58.3 Not reported CAMCOG Not reported n/a 85 28/40 (70%) 
Dementia 
(mod/sev) (22) 
n/a 27 
*Specificity means that the test correctly identified credible effort (i.e. the proportion of true negatives). 
±Sensitivity means that the test correctly identified non-credible effort (i.e. the proportion of true positives). 
 
MMSE = Mini-Mental State Examination   CAMCOG = Cambridge Cognitive Examination    
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3. The Coin in the Hand (CIH; Kapur, 1994). 
The Coin in the Hand Test (CIH) was developed to be a ‘simple, brief test designed to 
detect the presence of malingering in patients who are suspected of simulating poor memory 
performance’ (Kapur, 1994, p.385). It is a stand-alone, forced-choice test in which the 
clinician holds a coin in their right or left hand in front of the examinee who then closes their 
eyes and counts backwards from 10 before opening their eyes to report which hand the coin is 
in. A score of 7 or less out of 10 trials is used as the cut-off for this test. See Table 3 for the 
results of studies investigating the CIH. 
Two of the papers included in this review examined the utility of the CIH. Schroeder, 
Peck, Buddin, Heinrichs and Baade (2012) used a sample of 45 inpatients with a diagnosis of 
dementia. The Schroeder study performed fairly well on the CCAT (31/40). In order to 
ensure that their sample would put forth adequate effort on the CIH, Schroeder excluded 
participants involved in litigation or who were collecting disability payments and they also 
excluded any participant failing the RBANS Effort Scale. Using a cut-off score of ≤7, 
resulted in a specificity of 98% in the Schroeder sample. Using the same cut-off, Rudman et 
al. (2011) found specificity of 100% in their mild dementia sample compared to 77% in the 
moderate/severe sample. Specificity therefore is high with a CIH cut-off of ≤7 as long as the 
examinee is not too cognitively impaired. 
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Table 3. Coin in the Hand (CIH; Kapur, 1994) – all studies used a cut-off of ≤7/10. 
Study Sample (n) Mean 
Age 
(SD) 
Mean 
Education 
(SD) 
Impairment 
measure 
Mean Score 
on 
Impairment 
Measure (SD) 
 *CIH Specificity 
(%) 
Quality Rating score (CCAT) 
Schroeder et al. (2012)  Dementia (45) 77.98 
(7.05) 
12.76 
(3.02) 
MMSE 21.47 (5.71) 98 31/40 (78%) 
Rudman et al. (2011)  Dementia (mild) (20) 58.3 Not 
reported 
CAMCOG 88.60 (5.03) 100 
 
28/40 (70%) 
Dementia (mod/sev) (22) 62.45 (16.21) 77 
*Specificity means that the test correctly identified credible effort (i.e. the proportion of true negatives). 
 
MMSE = Mini-Mental State Examination   CAMCOG = Cambridge Cognitive Examination 
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4. Word Memory Test (WMT; Green, 2003). 
The WMT, MSVT and NV-MSVT, all devised by Green, are PVTs which are a departure 
from the traditional pass/fail effort tests in that they use profile analysis to determine an 
individual’s level of effort. They are based on a hierarchical approach in line with the criteria 
devised by Slick et al. (1999). On these PVTs, a participant’s score is first compared against a 
cut-off (a pass/fail approach) and then for those participants who fail, their profile of scores 
over several subtests is analysed. These tests are unique in that they allow the examiner to 
distinguish between failure due to poor effort and failure due to cognitive impairment. Green 
states that on the WMT, MSVT and NV-MSVT, people with genuine cognitive impairment 
produce a specific profile of results, different from the pattern of results produced by those 
exerting non-credible effort. To differentiate between the two, the difference between the 
mean scores on the easy and hard subtests is calculated. Individuals with a diagnosis of 
dementia invariably show easy-hard differences of at least 20 points on these subtests, 
whereas such significant differences are rarely present in people asked to feign impairment. 
This pattern of results is known as the ‘dementia profile’. These three effort tests are 
described and the literature evaluated in turn. 
 
The WMT is a word-list learning task that involves learning a list of 20 word pairs which 
are presented twice, either on a computer screen or spoken aloud by the examiner (as in the 
original oral version of the test). It contains multiple subtests of which the first two are 
specifically designed to measure effort (Immediate and Delayed Recognition), the remaining 
subtests are conventional memory subtests. As stated above, the profile of scores on the 
WMT subtests (particularly the difference between the effort subtests and the conventional 
memory subtests) can indicate whether individuals fail the test due to insufficient effort or to 
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the severity of their cognitive impairment. The results of the studies investigating the WMT 
can be found in Table 4. 
Merten, Bossink & Schmand (2007) found that whilst all their controls passed the WMT 
effort subtests, almost all of the AD participants failed it (90% failed both the Immediate and 
Delayed Recognition trials). It is important to note however, that the authors were not able to 
analyse the profile of scores on the two effort subtests against those of the conventional 
memory tests because normative data for a Dutch population were not available at the time of 
the study. This is a significant limitation of the Merten et al. (2007) study since the 
researchers were only able to look at whether participants passed or failed the effort subtests 
and were not able to look at the profile of their scores to investigate whether they indicated a 
‘dementia profile’. 
Green, Montijo and Brockhaus (2011) found that 41/65 (63%) of their dementia sample 
and 13/60 (21.6%) of their MCI sample failed the easy subtests of the WMT. Using profile 
analysis however they found that every participant with dementia exhibited a ‘dementia 
profile’ meaning there were no false positives. Regarding the MCI sample, only 2 of the 11 
participants who failed the easy subtests of the WMT, indicated a profile suggestive of poor 
effort, which represents a false-positive rate of 3.3% for the total sample. The study however 
scored 28/40 on the CCAT due to inadequate reporting such as missing demographic data. It 
should perhaps also be noted that the participants were not screened for potential financial 
incentives, meaning that it cannot be concluded that the 2 participants who generated a poor 
effort profile were real false-positives. 
Martins & Martins (2010) found that 67% of their MCI sample failed the easy subtests of 
the WMT however 95% produced a dementia profile therefore were not misclassified as 
exerting non-credible effort.  
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Table 4. Word Memory Test (WMT; Green, 2003). 
Study Sample (n) Mean Age 
(SD) 
Mean 
Education 
(SD) 
Impairment 
measure 
Mean Score 
on 
Impairment 
Measure (SD) 
% Failed 
easy subtests 
(met 
Criterion A) 
% Produced 
dementia 
profile (met 
Criterion A 
not Criterion 
B) 
*WMT 
Specificity 
(%) 
Quality Rating score 
Green et al. (2011)  Dementia 
group 1 (42) 
70.9 (8) Not reported CDR 1.05 (0.6) 71 100 100 28/40 (70%) 
Dementia 
group 2 (23) 
65.2 (8) 0.83 (0.35) 48 100 100 
MCI (60) 68.8 (8.9) 0.5 single 
domain (29) 
0.5 multi 
domain (31) 
21.6 96.7 96.7 
Controls (19) 55.8 (7.5) 0 0 n/a 100 
Martins & Martins 
(2010) 
MCI (21) 71.2 (2) Not reported WMS-III 
(Logical 
Memory 
Subtest) 
Not reported 67 95.2 95.2 30/40 (75%) 
**Merten et al. AD (20) 73.5 (4.8) 11.7 (3.3) MMSE 22.2 (2.9) **50 n/a **50 30/40 (75%) 
   
23 
 
(2007)  Controls (14) 76.6 (6.7) 11.3 (3.7) 28.9 (1.0) **100 **0 
*Specificity means that the test correctly identified credible effort (i.e. the proportion of true negatives).             **Based on subtests passed/failed – profile analysis not used.        
CDR = Clinical Dementia Rating   MMSE = Mini-Mental State Examination    AD = Alzheimer’s Dementia                                                                                                                               
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5. Medical Symptom Validity Test (MSVT; Green, 2004). 
The MSVT is a shorter, modified and easier version of the WMT. Five of the papers in this 
review examined the utility of the MSVT in people with dementia, MCI, cognitively intact 
controls and volunteers asked to simulate dementia and the results of these studies can be 
found in Table 5. Two of the papers were able to report sensitivity levels of 60% (simulators) 
and 100% (suspect effort MCI sample). Performance on the easy subtests was variable across 
the studies from only 12.5% of Howe et al’s (2007) MCI sample failing the subtests 
compared to 100% of Singhals’ simulator sample. More importantly however is that by using 
profile analysis, specificity levels for the MSVT across the 4 studies ranged from 80 -100%, 
meaning that very few individuals were misclassified as exhibiting poor effort. The exception 
was Rudman et al. (2011) who solely calculated effort based on whether participants had 
passed or failed the easy subtests. They did not use profile analysis. Although these results 
are promising, they should be treated as preliminary as the studies involved very small 
sample sizes. 
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Table 5.  Medical Symptom Validity Test (MSVT; Green, 2004). 
Study Sample (n) Mean Age 
(SD) 
Mean 
Education 
(SD) 
Impairment 
measure 
Mean Score 
on 
Impairment 
Measure (SD) 
% Failed 
easy 
subtests 
(met 
Criterion 
A) 
% Produce 
dementia 
profile 
(met 
Criterion 
A not 
Criterion 
B) 
±MSVT 
Sensitivity 
(%) 
*MSVT 
Specificity 
(%) 
Quality Rating 
score 
Suesse et al. 
(2015) 
Dementia (15) Not 
reported 
Not 
reported 
n/a n/a 19.7 86.7 n/a 86.7 28/40 (70%) 
Green et al. 
(2011) 
Dementia group 
1 (42) 
70.9 (8) Not 
reported 
CDR 1.05 (0.6) Not 
reported 
Not 
reported 
Not reported Not 
reported 
28/40 (70%) 
Dementia group 
2 (23) 
65.2 (8) 0.83 (0.35) 44 100 n/a 100 
MCI (60) 68.8 (8.9) 0.5 single 
domain (29) 
0.5 multi 
domain (31) 
Not 
reported 
Not 
reported 
n/a Not reported 
Controls (19) 55.8 (7.5) 0 Not 
reported 
Not 
reported 
n/a Not reported 
**Rudman et al. 
(2011) 
Dementia (mild) 
(20) 
58.3 Not 
reported 
CAMCOG 88.60 (5.03) 35 Not 
analysed 
n/a *65 28/40 (70%) 
Dementia 
(mod/sev) (22) 
62.45 (16.21) 72 n/a *28 
Singhal et al. Dementia (10) 81.7 (4.6) 10 (2.9) MMSE 15.5 (5.3) 100 100 n/a 100 31/40 (78%) 
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(2009) aSimulators (10) 36 (10) 17 (2) n/a 100 40 60 n/a 
Howe et al. 
(2007) 
Disability:   WAIS-III 
FSIQ 
FSIQ     35/40 (88%) 
Dementia (5) 56.60 
(4.95) 
11.60 
(2.30) 
82.20 (5.63) 60 100 n/a 100 
MCI (3) 44.33 
(19.50) 
13.33 
(2.31) 
89.33 (5.63) 66.7 0 100 n/a 
Controls (1) 58 13 102 0 n/a n/a n/a 
No Disability        FSIQ 
Dementia early 
(13) 
73.54 
(9.03) 
12 (2.42) 89.27 (14.54) 38.46 80 n/a 80 
Dementia 
advanced (18) 
76.39 
(6.89) 
13.83 (2.92) 86.77 (13.45) 83.33 86 n/a 86 
MCI (16) 69.50 
(9.60) 
15.75 (2.93) 100.94 (10.34) 12.5 100 n/a 100 
Controls (5) 57.20 
(17.33) 
15.40 (1.67) 107.80 (10.26) 0 n/a n/a n/a 
*Specificity means that the test correctly identified credible effort (i.e. the proportion of true negatives).  
±Sensitivity means that the test correctly identified non-credible effort (i.e. the proportion of true positives).  
**Based on subtests passed/failed – profile analysis not used.             
CDR = Clinical Dementia Rating   CAMCOG = Cambridge Cognitive Examination   MMSE = Mini-Mental State Examination   WAIS FSIQ = Wechsler Adult Intelligence Scale, Full 
Scale Intelligence Quotient                                                                                               
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6. Non-Verbal Medical Symptom Validity Test (NV-MSVT; Green, 2008) 
The NV-MSVT is the non-verbal equivalent of the MSVT. Three studies were found to 
investigate the diagnostic accuracy of this PVT in dementia and healthy controls and the 
results of these can be found in Table 6. 
As noted with the MSVT, Rudman et al. (2011) found low specificity of the NV-MSVT 
(33% in their overall dementia sample), however they did not use profile analysis therefore 
their results are not complete or accurate. Henry et al. (2010) found specificity of 100% in 
their controls and dementia sample and 97.7% in their non-dementia (neurological) sample 
whilst Singhal, Green, Ashaye, Shankar and Gill (2009) found 100% specificity for their 
institutionalised dementia patients. Interestingly, Singhal’s entire dementia sample failed the 
effort subtests of the NV-MSVT however they all showed a ‘dementia profile’ therefore they 
were not misclassified as malingering. They were also a particularly impaired sample 
(average MMSE of 15.5).  
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Table 6. Non-verbal Medical Symptom Validity Test (NV-MSVT; Green, 2008). 
Study Sample (n) Mean 
Age 
(SD) 
Mean 
Education 
(SD) 
Impairment 
measure 
Mean Score 
on 
Impairment 
Measure 
(SD) 
% Failed 
easy subtests 
(met 
Criterion A) 
% Produced 
dementia 
profile (met 
Criterion A not 
Criterion B) 
±NV-MSVT 
Sensitivity 
(%) 
* NV-MSVT 
Specificity 
(%) 
Quality Rating 
score 
**Rudman et al. 
(2011)  
Dementia (mild) 
(20) 
58.3 
 
Not 
reported 
CAMCOG 88.60 (5.03) 35 Not analysed n/a **65 28/40 (70%) 
Dementia 
(mod/sev) (22) 
62.45 
(16.21) 
72 n/a **28 
Henry et al. 
(2010) 
Dementia (21) 
Without 
dementia (n=44) 
59.1 
(16.1) 
13.1 (3.4) MMSE 25.7 (3.9) 61 
15 
61 
15 
n/a 100 
97.7 
28/40 (70%) 
Controls (50) 62.8 
(7.1) 
15.8 (3) 28.7 (1.1) 2 2 100 
Singhal et al. 
(2009) 
Dementia (10) 81.7 
(4.6) 
10 (2.9) MMSE 15.5 (5.3) 100 100 n/a 100 31/40 (78%) 
a Simulators 
(10) 
36 
(10) 
17 (2) n/a 90 40 60 n/a 
*Specificity means that the test correctly identified credible effort (i.e. the proportion of true negatives). 
±Sensitivity means that the test correctly identified non-credible effort (i.e. the proportion of true positives). 
**Based on subtests passed/failed – profile analysis not used.  aAsked to simulate memory impairment.  
CAMCOG = Cambridge Cognitive Examination   MMSE = Mini-Mental State Examination    
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7. Amsterdam Short Memory Test (ASTM; Schagen, Schmand, de Sterke & 
Lindeboom, 1998). 
The ASTM is a forced-choice test in which five examples from a category (e.g. 
animals, colours etc.) are read aloud by the examinee. A relatively simple mathematical 
problem is then presented to the examinee after which time another five words from the same 
category are presented. The examinee’s task is to recognise which three words are identical to 
those in the first list. The test maximum score is 90 and the cut-off is 84/85. Merten et al. 
(2007) found that all of their controls passed the ASTM however only 10% of their 
Alzheimer’s dementia participants passed the test (i.e. specificity, 10%) (see Table 7). Given 
that 70% of the same AD sample passed the TOMM, it would appear that the ASTM is 
unlikely to be an appropriate choice of PVT for individuals with cognitive impairment due to 
a possible dementia because the false-positive rate is likely to be high. 
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Table 7. Amsterdam Short-Term Memory Test (ASTM; Schagen, Schmand, de Sterke & Lindeboom, 1997) – results based on cut-off of 84/85. 
Study Sample (n) Mean Age 
(SD) 
Mean 
Education 
(SD) 
Impairment 
measure 
Mean Score on 
Impairment 
Measure (SD) 
*ASTM 
Specificity (%) 
Quality Rating score (CCAT) 
Merten et al. (2007) AD dementia 
(20) 
73.5 (4.8) 
 
11.7 (3.3) MMSE 22.2 (2.9) 
 
10 30/40 (75%) 
Controls (14) 76.6 (6.7) 11.3 (3.7) 28.9 (1.0) 100 
*Specificity means that the test correctly identified credible effort (i.e. the proportion of true negatives). 
MMSE = Mini-Mental State Examination 
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8. Dot Counting Test (DCT; Rey, 1941). 
The DCT is a task in which the examinee is presented with twelve cards containing 
different numbers of dots. The first six cards contain dots arranged in a random order and the 
following six cards contain grouped dots. Examinees are asked to count the dots as quickly as 
possible. The three studies investigating the DCT in dementia and control samples used 
different scoring methods (see Table 8). Dean et al. (2009) and Boone et al. (2002) used a 
scoring system whereby the mean ungrouped dot counting time, the mean grouped dot 
counting time and the error score are summed. They found poor specificity for their dementia 
samples (33.4-75%) but perfect specificity for their healthy controls. 
 Rudman et al. (2011) used the scoring recommended by Lezak (2004) which is that 
suspect effort is considered if the time taken to count the grouped dots is equal to or more 
than the time required to count the ungrouped dots. They found good specificity (90%) for 
their mild dementia sample but poor specificity (68%) for their moderate/severe sample. 
They used this scoring method because the combined score uses two measures of reaction 
time which they proposed to be inappropriate index to use with dementia samples as 
individuals with dementia typically experience a reduction in their processing skills. 
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Table 8. Dot Counting Test (DCT; Rey, 1941)  
Rudman et al. (2011) results based on “total ungrouped time< total group time”. 
Dean et al. (2009) and Boone et al. (2002) results based on ‘mean ungrouped dots counting time + error grouped dot counting time + errors” ≤17. 
Study Sample (n) Mean Age (SD) Mean 
Education 
(SD) 
Impairment 
measure 
Mean Score on 
Impairment 
Measure (SD) 
*DCT Specificity 
(%) 
Quality Rating score (CCAT) 
Rudman et al. (2011)  Dementia 
(mild) (20) 
58.3 Not reported CAMCOG 88.60 (5.03) 90 28/40 (70%) 
Dementia 
(mod/sev) (22) 
62.45 (16.21) 68 
Dean et al. (2009)  Dementia (80) Not reported Not reported MMSE 18.8 (5) 50 30/40 (75%) 
Boone et al. (2002) Dementia 
(mild) (16) 
75.4 (9.3) 12.7 (2.6) MMSE >20 75 21/40 (53%) 
Dementia 
(mod) 
78.1 (10.4) 13 (2.4) 10-20 33.4 
Controls 63.5 (8.8) 15.3 (2.4) n/a 100 
*Specificity means that the test correctly identified credible effort (i.e. the proportion of true negatives). 
CAMCOG = Cambridge Cognitive Examination   MMSE = Mini-Mental State Examination 
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9. Finger Tapping Test (FTT; Reitan & Wolfson, 1993). 
The Finger Tapping Test (FTT) is used in neuropsychology both as part of the Halstead-
Reitan Neuropsychological Test Battery (HRNB) and as a stand-alone PVT. See Table 9 for 
the results of the studies investigating the FTT in dementia and controls. The recommended 
cut-offs for dominant-hand finger tapping (women - ≤28, men ≤35) reveal poor specificity for 
the dementia groups across the two papers included in this review (69%-87%). Arnold et al. 
(2005), however provide various cut-offs for dominant hand, non-dominant hand, summed 
hands and difference between hands. They found 100% specificity for male dementia 
participants using a difference score of ≤-2 and 87% specificity for female dementia 
participants using a difference score of ≤5. Further analysis revealed differences in specificity 
values by dementia subgroup such that the dominant hand cut-off of ≤28 for women with 
Alzheimer’s disease (AD) was 83% whilst for females with non-AD dementias the specificity 
reduced to 64%. Similarly, a cut-off of >41 for the dominant hand identified 100% of men 
with AD dementia whilst only 37% of men with non-AD dementias achieved the same score.
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Table 9. Finger Tapping Test (FTT; Reitan & Wolfson, 1993). 
Study Sample (n) Mean 
Age 
(SD) 
Mean 
Education 
(SD) 
Impairment 
measure 
Mean Score 
on 
Impairment 
Measure (SD) 
 *FTT Specificity 
(%) 
Quality Rating score (CCAT) 
Dean et al. (2009) Dementia (80) Not 
reported 
Not 
reported 
MMSE 18.8 (5) Women 
Dom ≤28 69 
 
Men 
Dom ≤35 69 
30/40 (75%) 
Arnold et al. (2005) Dementia (31) 67.48 
(10.95) 
13.61 
(3.87) 
Not reported n/a Women  
Dom ≤28 75 
Non-dom ≤25 87 
Sum ≤58 80 
Difference ≤5 87 
 
Men 
Dom ≤35 87 
Non-dom ≤30 80 
Sum ≤66 71 
Difference ≤-2 100 
 
25/40 (63%) 
Controls (18) 66.67 
(6.51) 
17.89 
(2.06) 
Women 
Dom ≤28 100 
Non-dom ≤25 87  
Sum ≤58 100 
Difference ≤5 100 
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Men 
Dom ≤35 100 
Non-dom ≤30 100 
Sum ≤66 100 
Difference ≤-2 90 
 
*Specificity means that the test correctly identified credible effort (i.e. the proportion of true negatives). 
 
MMSE = Mini-Mental State Examination 
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Embedded PVTs 
1. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS; 
Randolph, Tierney, Mohr & Chase, 1998). 
The RBANS is a widely used neurocognitive battery commonly used in the assessment of 
dementia. Two RBANS embedded measures of effort have been developed: the Effort Index 
(EI; Silverberg, Wertheimer & Fichtenberg, 2007) and the Effort Scale (ES; Novitski, Steele, 
Karantzoulis & Randolph, 2012). Seven of the eight studies which investigated these 
embedded indices, examined the utility of the EI, four examined the utility of the ES and one 
paper compared both the EI and the ES against two novel RBANS embedded indices.  
 
a. RBANS Effort Index (EI; Silverberg, Wertheimer & Fichtenberg, 2007). The EI 
combines performance on two subtests (Digit Span and List Recognition) to produce 
an ‘effort index’. A score of greater than 3 is suggestive of non-credible effort. In the 
development of the EI, it was found that very poor performance on both these subtests was 
extremely rare in a mixed clinical sample of patients with neurological disorders. See Table 
10 for results of studies investigating the EI. 
All 4 of the studies which use a reference standard in order to divide participants into 
credible and non-credible effort groups, investigated the use of the EI. Sensitivity levels for 
the EI were 0.50, 0.89, 0.93 and 0.95. Unlike the TOMM studies, dementia severity does not 
appear to explain the differing sensitivity levels found for the EI. Bortnik et al. (2013) who 
report a sensitivity level of only 0.50 in their ‘suspect effort’ dementia sample also report that 
this group had a mean MMSE score of 17.9. Compare this to Paulson, Horner and Bachmann 
(2015) who found a sensitivity level of 0.93 in a dementia sample with a mean MMSE score 
of 23.1. It should be noted however that the Bortnik et al. (2013) study included a very small 
sample (n=9) and scored relatively poorly on the STARD (20/28) due to inadequate 
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reporting. Specificity levels were reported by all 7 papers and range from a low of 0.41 
(Dunham, Shadi, Sofko, Denney & Calloway) to a relative high of 0.69 (Bortnik, Horner & 
Bachman, 2013). Only controls and MCI samples produced acceptable levels of specificity 
on the EI. 
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Table 10. RBANS Effort Index (EI; Silverberg, Wertheimer & Fichtenberg, 2007) – all results refer to a cut-off of >3. 
Study Sample (n) Mean Age 
(SD) 
Mean 
Education 
(SD) 
Impairment 
measure 
Mean Score on 
Impairment Measure 
(SD) 
±Effort Index 
Sensitivity (%) 
*Effort Index 
Specificity (%) 
Quality Rating score  
Paulson et al. (2015)  Good effort 
(189) 
69.2 (9.4) 12.9 (3.2) MMSE 
 
RBANS Total 
scores 
27.5 (2.2) MMSE 
85 (12.2) RBANS 
n/a 63 27/28 (96%) 
Suspect effort 
(45) 
64.2 (10.9) 12.3 (2.9) 23.1 (4.9) MMSE 
59.9 (10.7) RBANS 
93 n/a 
Burton et al. (2015) AD (90) Not 
reported 
Not reported CDR Not reported n/a 51 27/40 (68%) 
Non-AD 
dementia (55) 
n/a 54 
Dunham et al. (2014) Dementia (46) 76.44 
(10.49) 
11.17 (2.82) RBANS Total 
scores 
57.48 (11.70) n/a 41 20/28 (71%) 
aSimulators 
(44) 
27.82 
(9.01) 
16.41 (0.82) 48.52 (8.66) 89 n/a 
Bortnik et al. (2013) Good effort 
(119) 
77 (7) 11.42 (4) MMSE 20.8 (5) n/a 69.6 20/28 (71%) 
Suspect effort 
(9) 
72 (8.13) 10.44 (2.3) 17.9 (4.5) 50 n/a 
Novitski et al. (2012) aMCI (15) 80.61 
(6.33) 
Not reported RBANS total 
scores 
64.58 (12.89) n/a Not reported 
(AUC 0.608) 
21/40 (53%) 
Probable AD 
(54) 
n/a Not reported 
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Controls (540) n/a Not reported 
Duff et al. (2011) AD (126) 76.7 (6.8) <9yrs=12 
9-11yrs=14 
12yrs= 38 
13-15yrs=10 
>15yrs=26 
RBANS Total 
scores 
65.9 (5.9) n/a 67.1 31/40 (78%) 
aMCI (72) 72 (82.1) <9yrs=0 
9-11yrs=3 
12yrs=17 
13-15yrs=23 
>15yrs=57 
92.3 (9.1) n/a 100 
Controls (796) 73.4 (5.9) <9yrs=5 
9-11yrs=11 
12yrs=26 
13-15yrs=30 
>15yrs=28 
95.7 (13.3) n/a 97.1 
Barker et al. (2010) Suspect effort 
(45) 
67.1 (10.3) 12 (3) RBANS total 
index scores 
IM 57 (16.4) 
DM 51.6 (14.7) 
A 60.7 (15.6) 
L 72 (20.6) 
VS 70.7 (20.9) 
n/a 42.2 22/28 (79%) 
Good effort 
(258) 
72.5 (8.8) 12.5 (3.5) IM 75.1 (15.8) 
DM 76 (19.9) 
A 81.9 (16.1) 
L 88.3 (10.6) 
VS 84.3 (17.7) 
95.3 n/a 
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*Specificity means that the test correctly identified credible effort (i.e. the proportion of true negatives).  
±Sensitivity means that the test correctly identified non-credible effort (i.e. the proportion of true positives).  
 
MMSE = Mini-Mental State Examination   RBANS = Repeatable Battery for the Assessment of Neuropsychological Status        CDR = Clinical Dementia Rating                                                     
aMCI = amnestic MCI    AD = Alzheimer’s Dementia    IM = Immediate Memory   DM = Delayed Memory   A = Attention    L = Language   VS – Visuospatial                                
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 b. RBANS Effort Scale (ES; Novitski, Steele Karantzoulis & Randolph, 2012). The 
RBANS Effort Scale is based on the premise that when an individual has genuine memory 
impairment, their performance on free recall tasks (List Recall, Story Recall and Figure 
Recall subtests) will decline to close to zero before decline in List Recognition is seen. The 
authors of the ES propose a cut-off of <12 as being suggestive of non-credible effort (the ES 
calculation is: List Recognition – (List Recall + Story Recall + Figure Recall)) + Digit Span). 
See Table 11 for studies investigating the ES. 
The studies investigating the ES scored relatively poorly on the quality checklists due 
to inadequate and/or missing information making it difficult to examine the results across 
studies. In the original validation study, Novitski et al. (2012) compared dementia and MCI 
participants with a poor effort group of mild head injury participants, they report an 
impressive area under the curve (AUC) of 0.908. The paper scored poorly however on the 
CCAT (21/40) due to inadequate information given regarding data collection, inclusion and 
exclusion criteria and participant demographic information.  
Burton, Enright, O’Connell, Lanting & Morgan (2015) compared the ES in AD and 
non-AD dementias. They found an impressively high specificity level of 0.96 in their AD 
sample, however this fell to 0.69 in their non-AD sample. The authors conclude that the ES 
may be an appropriate effort index to use when assessing effort level in people with a 
dementia of the Alzheimer’s type, however in clinical practice, effort tests are most likely to 
be given during the diagnostic process when a person’s diagnosis is as yet unknown. It does 
raise the issue that the ES is based on the premise that a person’s performance on tests of free 
recall will decline before their performance on tests of recognition. This profile of 
impairment is more likely to be seen in AD, which is characterised by a deficit in episodic 
memory, than in non-AD dementias. 
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Paulson et al. (2015) and Dunham et al. (2014) investigated the ES in both good and 
suspect effort groups. They found sensitivity of 0.71 and 0.88 and specificity levels of 0.42 
and 0.81 respectively. It is not clear why the studies found very different specificity levels 
and due to inadequate reporting by the studies it was impossible to investigate whether type 
of dementia had a bearing on the discrepancy in the results found (i.e. if the reason for the 
high failure rate in Paulson’s good effort group was due to the majority having a non-AD 
dementia). 
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Table 11. RBANS Effort Scale (ES; Novitski, Steele, Karantzoulis & Randolph) – all results refer to a cut-off of <12. 
Study Sample (n) Mean Age 
(SD) 
Mean 
Education 
(SD) 
Impairment 
measure 
Mean Score on 
Impairment 
Measure (SD) 
±Effort Scale 
Sensitivity (%) 
*Effort Scale 
Specificity (%) 
Quality Rating score  
Paulson et al. (2015)  Good effort 
(189) 
69.2 (9.4) 12.9 (3.2) MMSE 
RBANS Total 
scores 
27.5 (2.2) 
MMSE 
85 (12.2) 
RBANS 
n/a 42 27/28 (96%) 
Suspect effort 
(45) 
64.2 (10.9) 12.3 (2.9) 23.1 (4.9) 
MMSE 
59.9 (10.7) 
RBANS 
71 n/a 
Burton et al. (2015)  AD dementia 
(53) 
Not reported Not reported CDR Not reported n/a 96 
 
69 
27/40 (68%) 
Non-AD 
dementia (36) 
n/a 
Dunham et al. (2014) Dementia (46) 76.44 (10.49) 11.17 (2.82) RBANS Total 
scores 
57.48 (11.70) n/a 81 20/28 (71%) 
aSimulators 
(44) 
27.82 (9.01) 16.41 (0.82) 48.52 (8.66) 88 n/a 
Novitski et al. (2012) aMCI (15) 80.61 (6.33) Not reported RBANS total 
scores 
64.58 (12.89) n/a Not reported 
(AUC 0.908) 
21/40 (53%) 
probable AD 
(54) 
Not reported 
Controls (540) 84.9 
*Specificity means that the test correctly identified credible effort (i.e. the proportion of true negatives). MMSE = Mini–Mental State Examination   CDR = Clinical Dementia Rating 
±Sensitivity means that the test correctly identified non-credible effort (i.e. the proportion of true positives).  RBANS = Repeatable Battery for the Assessment of Neuropsychological Status 
AD = Alzheimer’s Dementia  
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b. Performance Validity Index (PVI; Paulson, Horner & Bachman, 2015) and 
Charleston Revised Index of Effort for RBANS (CRIER; Paulson, Horner & Bachman, 
2015). Paulson and colleagues evaluated the EI and ES against two novel RBANS 
embedded indices of effort, the PVI and the CRIER. The PVI cut-off for detecting 
invalid responding is <42 and is calculated as follows: 
 
RBANS PVI: List recall + story recall + figure recall + digit span + list recognition 
 
The CRIER cut-off for detecting invalid responding is <24 and is calculated as follows: 
 
RBANS CRIER: list recall + story recall + figure recall + digit span + list recognition – GDS 
 
The PVI was found to have sensitivity of 0.82, specificity of 0.77 and AUC of 0.90 whilst 
the CRIER had sensitivity of 0.84, specificity of 0.90 and AUC of 0.94. These are promising 
results and warrant further research. 
 
2. Reliable Digit Span (RDS; Greiffenstein, Baker & Gola, 1994). 
Greiffenstein, Baker, and Gola (1994) originally derived the RDS from the Digit Span 
subtest of the Wechsler Adult Intelligence Scale–Revised (Wechsler, 1981) by ‘summing the 
longest string of digits repeated without error over two trials under both forward and 
backward conditions’ (pp. 219-220). Table 12 illustrates the results of studies investigating 
the RDS. 
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RDS specificity was found to be greatly impacted by severity of cognitive 
impairment. It had high specificity for Loring’s dementia (87%), MCI (96%) and control 
samples (97%) and also for Zenisek’s (2016) MCI sample (94.6%) whilst Kiewel, Wisdom, 
Bradshaw, Pastorek and Strutt (2012) found high specificity for their mild dementia sample 
(89%). All of these samples had MMSE scores of 23 or more (except for Zenisek et al. 2016 
who used the MoCA). In contrast, with Kiewel’s more impaired groups, the RDS yielded an 
unacceptably high level of false positives similar to those in the equally impaired Dean et al. 
(2009) study. Zenisek et al. (2016) divided their sample into subgroups based on type of 
dementia diagnosed and found differences in specificity levels with a high of 85.2 for 
dementia with Lewy bodies sample and a low of 73.3 for their frontotemporal dementia 
sample.
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Table 12. Reliable Digit Span (RDS; Greiffenstein, Baker & Gola, 1994) – all results refer to a cut-off of ≤6. 
Study Sample (n) Mean Age 
(SD) 
Mean 
Education 
(SD) 
Impairment 
measure 
Mean Score 
on 
Impairment 
Measure (SD) 
*RDS Specificity 
(%) 
Quality Rating score (CCAT) 
Zenisek et al. (2016) AD (133) 72.6 (7.8) 14.8 (2.9) MoCA 21 (4.8) 80.5 23/40 (58%) 
VAD (8) 75 
DLB (27) 85.2 
FTD (15) 73.3 
MCI (168) 94.6 
Loring et al. (2016) AD (178) 75.7 (7.5) Not reported MMSE 23.3 (2) 87 31/40 (78%) 
aMCI (365) 74.9 (7.2) 27 (1.8) 96 
Controls (206) 76 (5) 29.1 (1) 97 
Kiewel et al. (2012) Dementia 
(mild) 
74.6 (8.8) 14.5 (2.7) MMSE 23.4 (3.1) 89 30/40 (75%) 
Dementia 
(mod) 
76.5 (9.4) 14.2 (2.7) 16.8 (2.9) 76 
Dementia (sev) 71.2 (10.6) 13.5 (2.7) 7.7 (3.4) 17 
Dean et al. (2009)  Dementia 
(172) 
Not reported Not reported MMSE 19.2 (4.4) 70 30/40 (75%) 
*Specificity means that the test correctly identified credible effort (i.e. the proportion of true negatives).    MMSE = Mini-Mental State Examination     aMCI = amnestic MCI 
AD = Alzheimer’s Dementia     VAD = Vascular Dementia      DLB = Dementia with Lewy Bodies     FTD = Frontotemporal Dementia    
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Discussion 
This review included 25 papers examining the diagnostic accuracy of 14 embedded 
and stand-alone tests of effort in dementia and MCI samples. In particular this review sought 
to establish which PVTs were most sensitive to non-credible effort whilst being insensitive to 
the cognitive impairment seen in individuals who meet criteria for these diagnoses. The effort 
tests which were found to be most sensitive to non-credible effort whilst being least sensitive 
to dementia-related cognitive impairment were the three PVTs devised by Green (2003, 2004, 
2008). The WMT, MSVT and NV-MSVT go beyond the pass/fail approach of traditional 
effort tests and instead use profile analysis to determine if the pattern of results which an 
examinee produces are indicative of poor effort or if they show a ‘dementia profile’. The vast 
majority of the studies which investigated these tests found 100% specificity. The only 
studies which found low levels of specificity for these PVTs were those which calculated 
Criterion A only and did not use profile analysis to determine effort level (i.e. determined 
effort level on whether the participants scored below cut-off on the effort tests but did not 
determine whether a dementia profile was present). The WMT, MSVT and NV-MSVT 
therefore appear to be the most appropriate effort tests for use in cognitive assessment when a 
dementia is queried. These results should be taken as provisional however since, although the 
evidence is promising there is not a wealth of literature to draw from. It should also be noted 
that producing a “dementia profile” is not in itself proof of adequate effort and that clinicians 
should aim to employ a multi-method approach to effort testing such as that devised by Slick 
et al. (1999) to highlight any inconsistencies between PVT results and information gathered 
from other sources. Some of the other tests explored in this review were found to have 
acceptable specificity levels when used with MCI or mild dementia samples such as the 
TOMM, the Coin in the Hand and the RDS. These PVTs do however lose specificity with 
more impaired samples.  
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Methodological limitations of effort testing literature 
Compared to other areas of research in clinical neuropsychology, effort testing 
research faces significant methodological challenges since no ‘gold-standard’ exists with 
which to reliably determine performance validity. Five of the 25 papers included in this 
review attempted to independently assess effort by use of a reference standard (three used the 
TOMM, one used the MSVT and one used the RBANS Effort Scale). The remaining 20 
papers either excluded participants who may have had an incentive to feign impairment or 
they assumed good effort by virtue of the participants having a diagnosis of dementia. This 
makes it difficult to know what the true false-positive rate actually is. 
Diagnostic tests should be evaluated in samples that are representative of those with 
whom the test will be used in practice. The majority of the studies included in this review use 
a methodology whereby participants with an established dementia are compared to healthy 
controls. This is likely to lead to bias since the participants included have a more advanced 
stage of the disease (in this case dementia) than studies using a clinical sample of consecutive 
referrals to memory clinics. Indeed there appears to be a positive correlation between PVT 
specificity and severity of cognitive impairment, such that as scores on cognitive tests 
decrease, so too does the specificity level of a PVT. 
Also, very few of the studies included samples with a diagnosis of MCI, a population 
of importance when evaluating the diagnostic accuracy of effort tests in older adults 
presenting with memory difficulties. Additionally, very few of the studies included in this 
review were able to assess sensitivity levels because they only included participants who 
were deemed to exert credible effort from the outset, either due to not being involved in 
litigation/claiming disability benefits or simply by virtue of having a diagnosis of dementia.  
Finally, the studies included in this review largely approach the subject of effort in its 
‘malingering’ definition whereby examinees are deemed to be feigning impairment. As 
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discussed previously, indications of poor or atypical motivation are not always the result of 
deliberate malingering, rather there are many reasons for an individual to put forth less than 
credible effort such as low mood, stress, conversion disorder, medication side effects and 
fatigue amongst others. The majority of the studies in this review did not assess for these 
factors. 
 
Methodological limitations of the current review 
This systematic review faced some methodological limitations. First, it was out with 
the scope of the review to include every study which has investigated the diagnostic utility of 
PVTs in dementia samples. The current study focused on papers which included 
dementia/MCI samples as their primary interest. There are, however, other studies which 
include a dementia sample alongside other clinical samples. Additionally, as previously 
mentioned, it was also out with the scope of the current review to examine every PVT 
investigated by the papers included therefore only the PVTs which are known to be most 
used in clinical practice were reviewed. 
Finally, some of the studies examined the performance of the PVTs across different 
cut-offs. It was not possible to review each of these cut-offs therefore those most used in 
clinical practice were evaluated. 
 
Conclusions 
Future research on the diagnostic accuracy of PVTs in older adults should aim to 
focus on the recruitment of consecutive referrals to memory clinics and should employ a 
multi-method approach such as that proposed by Slick et al. (1999). As part of the cognitive 
test battery, the participants should receive a reference standard (such as the MSVT or NV-
MSVT) and the PVT of interest (the index test). The index test should only be calculated 
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once the final diagnosis is known. This method would allow for both sensitivity and 
specificity of the PVT in question to be investigated since both good effort and suspect effort 
participants would be included. Future research should also seek to review the diagnostic 
utility of PVTs across various cut-offs in MCI/dementia samples. Future research may also 
seek to further evaluate the use of the two new RBANS embedded indices (PVI and CRIER) 
created by Paulson et al. (2015) as these showed good potential and the RBANS is a 
commonly used tool in older adult memory clinics. It is also important for future research to 
look at subtypes of dementia and how profiles of impairment impact PVT performance. It is 
likely that some of the variation in performance seen across the different studies may be 
partially accounted for not just by dementia severity but by dementia subtype. Burton et al. 
(2015) touched on this issue when they found that the Effort Scale had significantly higher 
specificity in their Alzheimer’s sample (96%) compared to their non-Alzheimer sample 
(69%). 
Following evaluation of the studies in this review, tests which take a hierarchical 
approach to effort testing such as the WMT, MSVT and the NV-MSVT may be the best 
PVTs to use in clinical practice given that these tests have been found to be particularly 
robust in dementia samples (i.e. they have very low false-positive rates). It should be noted 
however that Green’s tests can be lengthy to administer which may be outwith the scope of 
some clinical contexts.  
Finally it must be stressed that determining an individual’s level of effort should not 
be judged on the basis of scores on an effort test alone. It should also be noted that the vast 
majority of older people referred for memory assessment will have no incentive to 
purposefully feign impairment. 
 
 
   
51 
 
Funding 
This study was supported by NHS Greater Glasgow and Clyde. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
52 
 
References 
Arnold G., Boone K.B., Lu P., Dean A., Wen J., Nitch S., & McPherson, S. (2005). 
Sensitivity and specificity of finger tapping test scores for the detection of suspect effort. 
Clinical Neuropsychologist, 19(1), 105-120 
Ashendorf, L., Constantinou, M., & McCaffrey, R. J. (2004). The effect of depression and 
anxiety on the TOMM in community-dwelling older adults. Archives of Clinical 
Neuropsychology, 19(1), 125-130.  
Barker, M. D., Horner, M. D., & Bachman, D. L. (2010). Embedded indices of effort in the 
repeatable battery for the assessment of neuropsychological status (RBANS) in a 
geriatric sample. The Clinical Neuropsychologist, 24(6), 1064-1077.  
Boone, K. B., & Lu, P. H. (1999). Impact of somatoform symptomatology on credibility of 
cognitive performance. Clinical Neuropsychologist, 13(4), 414-419.  
Boone, K. B., Salazar, X., Lu, P., Warner-Chacon, K., & Razani, J. (2002). The rey 15-item 
recognition trial: A technique to enhance sensitivity of the rey 15-item memorization 
test. Journal of Clinical and Experimental Neuropsychology, 24(5), 561-573. 
Bortnik, K. E., Horner, M. D., & Bachman, D. L. (2013). Performance on standard indexes of 
effort among patients with dementia. Applied Neuropsychology: Adult, 20(4), 233-242.  
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L., . . . 
Cohen, J. F. (2015). STARD 2015: An updated list of essential items for reporting 
diagnostic accuracy studies. Radiology, 277(3), 826-832.  
   
53 
 
Burton, R. L., Enright, J., O'Connell, M.,E., Lanting, S., & Morgan, D. (2015). RBANS 
embedded measures of subcredible effort in dementia: Effort scale has a lower failure 
rate than the effort index. Archives of Clinical Neuropsychology: The Official Journal of 
the National Academy of Neuropsychologists, 30(1), 1-6.  
Crowe, M., & Sheppard, L. (2011). A general critical appraisal tool: an evaluation of 
construct validity. International Journal of Nursing Studies, 48(12), 1505–1516.  
Dean A.C., Victor T.L., Boone K.B., Philpott L.M., & Hess, R. A. (2009). Dementia and 
effort test performance. Clinical Neuropsychologist, 23(1), 133-152. 
Duff, K., Spering, C. C., O'Bryant, S. E., Beglinger, L. J., Moser, D. J., Bayless, J. D., . . . 
Scott, J. G. (2011). The RBANS effort index: Base rates in geriatric samples. Applied 
Neuropsychology, 18(1), 11-17.  
Dunham, K. J., Shadi, S., Sofko, C. A., Denney, R. L., & Calloway, J. (2014). Comparison of 
the repeatable battery for the assessment of neuropsychological status effort scale and 
effort index in a dementia sample. Archives of Clinical Neuropsychology: The Official 
Journal of the National Academy of Neuropsychologists, 29(7), 633-641.  
Faust, D., Hart, K., & Guilmette, T. J. (1988). Pediatric malingering: The capacity of children 
to fake believable deficits on neuropsychological testing. Journal of Consulting and 
Clinical Psychology, 56(4), 578-582. 
Faust, D. (1995). The detection of deception. Neurologic Clinics, 13(2), 255-265. 
Green, P. (2003). Word Memory Test for Windows: User’s manual and program. Edmonton: 
Green’s Publishing. 
   
54 
 
Green, P. (2008). Test manual for the nonverbal Medical Symptom Validity Test. Edmonton: 
Green’s Publishing.  
Green P., Montijo J., & Brockhaus, R. (2011). High specificity of the word memory test and 
medical symptom validity test in groups with severe verbal memory impairment. Applied 
Neuropsychology, 18(2), 86-94. 
Green, P., Rohling, M. L., Lees-Haley, P., & Allen, L. M. I.,II. (2001). Effort has a greater 
effect on test scores than severe brain injury in compensation claimants. Brain 
Injury, 15(12), 1045-1060.  
Greiffenstein, M. F., Baker, W. J., & Gola, T. (1994). Validation of malingered amnesia 
measures with a large clinical sample. Psychological Assessment, 6(3), 218-224.  
Hampson, N. E., Kemp, S., Coughlan, A. K., Moulin, C. J. A., & Bhakta, B. B. (2014). Effort 
test performance in clinical acute brain injury, community brain injury, and epilepsy 
populations. Applied Neuropsychology: Adult, 21(3), 183-194.  
Heaton, R. K., Smith, H. H. J., Lehman, R. A., & Vogt, A. T. (1978). Prospects for faking 
believable deficits on neuropsychological testing. Journal of Consulting & Clinical 
Psychology, 46(5), 892-900. 
Heilbronner, R. L., Sweet, J. J., Morgan, J. E., Larrabee, G. J., Millis, S. R., & Participants1, 
C. (2009). American academy of clinical neuropsychology consensus conference 
statement on the neuropsychological assessment of effort, response bias, and 
malingering. The Clinical Neuropsychologist, 23(7), 1093-1129. 
doi:10.1080/13854040903155063  
   
55 
 
Heinik, J., Solomesh, I., & Berkman, P. (2004). Correlation between the CAMCOG, the 
MMSE, and three clock drawing tests in a specialized outpatient psychogeriatric 
service. Archives of Gerontology and Geriatrics, 38(1), 77-84. 
Henry M., Merten T., Wolf S.A., & Harth, S. (2010). Nonverbal medical symptom validity 
test performance of elderly healthy adults and clinical neurology patients. Journal of 
Clinical and Experimental Neuropsychology, 32(1), 19-27. 
Howe L.L.S., Anderson A.M., Kaufman D.A.S., Sachs B.C., & Loring, D. W. (2007). 
Characterization of the medical symptom validity test in evaluation of clinically referred 
memory disorders clinic patients. Archives of Clinical Neuropsychology, 22(6), 753-761. 
Kapur, N. (1994). The coin-in-the-hand test: A new "bed-side" test for the detection of 
malingering in patients with suspected memory disorder. Journal of Neurology, 
Neurosurgery, and Psychiatry, 57(3), 385-386. 
Kiewel, N. A., Wisdom, N. M., Bradshaw, M. R., Pastorek, N. J., & Strutt, A. M. (2012). A 
retrospective review of digit span-related effort indicators in probable alzheimer's 
disease patients. The Clinical Neuropsychologist, 26(6), 965-974.  
Larrabee, G. J. (2012). Performance validity and symptom validity in neuropsychological 
assessment. Journal of the International Neuropsychological Society, 18, 1-7. 
Lezak, M.D., Howieson, D.B., Loring, H.J., & Fischer, J.S. (2004). Neuropsychological 
assessment (4th ed.). New York: Oxford University Press. 
Loring, D. W., Goldstein, F. C., Chen, C., Drane, D. L., Lah, J. J., Zhao, L., & Larrabee, G. J. 
(2016). False-positive error rates for reliable digit span and auditory verbal learning test 
   
56 
 
performance validity measures in amnestic mild cognitive impairment and early 
alzheimer disease. Archives of Clinical Neuropsychology: The Official Journal of the 
National Academy of Neuropsychologists, 31(4), 313-331.  
Martins, M., & Martins, I. P. (2010). Memory malingering: Evaluating WMT criteria. 
Applied Neuropsychology, 17(3), 177-182. doi:10.1080/09084281003715709 
McCarter, R. J., Walton, N. H., Brooks, D. N., & Powell, G. E. (2009). Effort testing in 
contemporary UK neuropsychological practice. The Clinical Neuropsychologist, 23(6), 
1050-1066.  
McMillan, T. M., Anderson, S., Baker, G., Berger, M., Powell, G. E., & Knight, R. (2009). 
Assessment of effort in clinical testing of cognitive functioning for adults. Leicester: 
British Psychological Society. 
Merten T., Bossink L., & Schmand, B. (2007). On the limits of effort testing: Symptom 
validity tests and severity of neurocognitive symptoms in nonlitigant patients. Journal of 
Clinical and Experimental Neuropsychology, 29(3), 308-318. 
Mittenberg W., Patton C., Canyock E.M., & Condit, D. C. (2002). Base rates of malingering 
and symptom exaggeration. Journal of Clinical and Experimental 
Neuropsychology, 24(8), 1094-1102. 
Novitski, J., Steele, S., Karantzoulis, S., & Randolph, C. (2012). The repeatable battery for 
the assessment of neuropsychological status effort scale. Archives of Clinical 
Neuropsychology: The Official Journal of the National Academy of 
Neuropsychologists, 27(2), 190-195.  
   
57 
 
Paulson, D., Horner, M. D., & Bachman, D. (2015). A comparison of four embedded validity 
indices for the RBANS in a memory disorders clinic. Archives of Clinical 
Neuropsychology: The Official Journal of the National Academy of 
Neuropsychologists, 30(3), 207-216.  
Randolph, C., Tierney, M. C., Mohr, E., & Chase, T. N. (1998). The repeatable battery for the 
assessment of neuropsychological status (RBANS): Preliminary clinical 
validity. Journal of Clinical & Experimental Neuropsychology: Official Journal of the 
International Neuropsychological Society, 20(3), 310-319. 
Reitan, R.M., & Wolfson, D. (1985). The Halstead-Reitan Neuropsychological Test Battery: 
Theory and Interpretation. Tucson, AZ: Neuropsychology Press.  
Rey, A. (1941). L'examen psychologique dans les cas d'encéphalopathie traumatique. (les 
problems.). = the psychological examination in cases of traumatic encepholopathy. 
problems. Archives De Psychologie, 28, 215-285. 
Rey, A. (1964). L’examen clinique en psychologie. Paris: Presses Universitaires de France. 
Rudman N., Oyebode J.R., Jones C.A., & Bentham, P. (2011). An investigation into the 
validity of effort tests in a working age dementia population. Aging & Mental 
Health, 15(1), 47-57. 
Schagen, S., Schmand, B., de Sterke, S., & Lindeboom, J. (1997). Amsterdam Short-Term 
Memory test: a new procedure for the detection of feigned memory deficits. Journal of 
Clinical and Experimental Neuropsychology, 19, 43–51. 
   
58 
 
Schroeder, R. W., Martin, P. K., & Odland, A. P. (2016). Expert beliefs and practices 
regarding neuropsychological validity testing. The Clinical Neuropsychologist, 30(4), 
515-535.  
Schroeder R.W., Peck C.P., Buddin W.H., Heinrichs R.J., & Baade, L. E. (2012). The coin-
in-the-hand test and dementia: More evidence for a screening test for neurocognitive 
symptom exaggeration. Cognitive and Behavioral Neurology, 25(3), 139-143. 
Scottish Intercollegiate Guidelines Network (SIGN). 2007. Methodology checklist 5: studies 
of diagnostic accuracy. In A Guideline Developer’s Handbook. SIGN: Edinburgh, 
Annex B. 
Silverberg, N. D., Wertheimer, J. C., & Fichtenberg, N. L. (2007). An effort index for the 
repeatable battery for the assessment of neuropsychological status (RBANS). The 
Clinical Neuropsychologist, 21(5), 841-854. 
Singhal A., Green P., Ashaye K., Shankar K., & Gill, D. (2009). High specificity of the 
medical symptom validity test in patients with very severe memory 
impairment. Archives of Clinical Neuropsychology, 24(8), 721-728. 
Slick, D. J., Sherman, E. M., & Iverson, G. L. (1999). Diagnostic criteria for malingered 
neurocognitive dysfunction: Proposed standards for clinical practice and 
research. Clinical Neuropsychologist, 13(4), 545-561. 
Slick, D. J., Tan, J. E., Strauss, E. H., & Hultsch, D. F. (2004). Detecting malingering: A 
survey of experts' practices. Archives of Clinical Neuropsychology: The Official Journal 
of the National Academy of Neuropsychologists, 19(4), 465-473. 
   
59 
 
Suesse M., Wong V.W., Stamper L.L., Carpenter K.N., & Scott, R. B. (2015). Evaluating the 
clinical utility of the medical symptom validity test (MSVT): A clinical series. The 
Clinical Neuropsychologist, 29(2), 214-231. 
Teichner, G., & Wagner, M. T. (2004). The test of memory malingering (TOMM): 
Normative data from cognitively intact, cognitively impaired, and elderly patients with 
dementia. Archives of Clinical Neuropsychology: The Official Journal of the National 
Academy of Neuropsychologists, 19(3), 455-464. 
Tombaugh, T.N. (1996). The test of memory malingering. Toronto, ON, Canada: MultiHealth 
Systems.  
Tombaugh,T. N. (1997). The test of memory malingering (TOMM): Normative data from 
cognitively intact and cognitively impaired individuals. Psychological Assessment, 9(3), 
260-268. 
van Gorp, W. G., Humphrey, L. A., Kalechstein, A., Brumm, V. L., McMullen, W. J., 
Stoddard, M., & Pachana, N. A. (1999). How well do standard clinical 
neuropsychological tests identify malingering? A preliminary analysis. Journal of 
Clinical and Experimental Neuropsychology, 21(2), 245-250.  
van, d. W., Prins, J. B., Jongen, P. J. H., van, d. M., & Bleijenberg, G. (2000). Abnormal 
neuropsychological findings are not necessarily a sign of cerebral impairment: A 
matched comparison between chronic fatigue syndrome and multiple 
sclerosis. Neuropsychiatry, Neuropsychology, & Behavioral Neurology, 13(3), 199-203. 
Walter J., Morris J., SwierVosnos A., & Pliskin, N. (2014). Effects of severity of dementia on 
a symptom validity measure. The Clinical Neuropsychologist, 28(7), 1197-1208. 
   
60 
 
Zenisek R., Millis S.R., Banks S.J., & Miller, J. B. (2016). Prevalence of below-criterion 
reliable digit span scores in a clinical sample of older adults. Archives of Clinical 
Neuropsychology : The Official Journal of the National Academy of Neuropsychologists, 
31(5), 426-433.  
 
